UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000019560
Receipt number R000022619
Scientific Title Randomized, Double-Blind, Phase III Trial of Olaparib vs. Placebo in Patients with Advanced FIGO Stage IIIB-IV High Grade Serous or Endometrioid Ovarian, Fallopian Tube, or Peritoneal Cancer treated with standard First-Line Treatment, Combining Platinum-Taxane Chemotherapy and Bevacizumab Concurrent with Chemotherapy and in Maintenance
Date of disclosure of the study information 2015/10/29
Last modified on 2024/03/06 17:46:46

No. Disposal Last modified on Item of update
1 Insert 2015/10/29 18:05:48
2 Update 2015/11/06 15:12:33 Acronym
Acronym
3 Update 2015/12/03 23:16:22 Recruitment status
4 Update 2016/04/27 09:09:10 Interventions/Control_1
Interventions/Control_2
5 Update 2016/04/27 09:12:21 Name of primary person or sponsor
Organization
Institutions
6 Update 2017/04/19 15:38:51 Last name of contact person
Last name of contact person
Organization
Organization
Name of person sending information
Name of person sending information
Organization
Organization
Organization
Organization
Institutions
7 Update 2017/04/19 15:40:27 Recruitment status
8 Update 2017/11/07 16:35:29 Last name of lead principal investigator
Last name of lead principal investigator
Organization
Organization
Division name
Division name
Address
Address
TEL
Email
Last name of contact person
Last name of contact person
Organization
Organization
Division name
Division name
Address
Address
Name of person sending information
Name of person sending information
Organization
Address
Address
Email
9 Update 2017/11/07 16:41:13 Address
10 Update 2017/11/09 09:05:33 Address
Address
11 Update 2018/05/01 12:55:07 Name of person sending information
Name of person sending information
Organization
Address
12 Update 2019/11/01 13:42:14 Publication of results
Number of participants that the trial has enrolled
13 Update 2020/05/11 13:39:45 Recruitment status
Date of IRB
14 Update 2020/12/02 11:56:07 Date of closure to data entry
Date trial data considered complete
Date analysis concluded
15 Update 2022/05/23 15:20:32 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Email
Organization
Organization
Address
Email
Organization
Organization
Address
Address
Tel
Email
16 Update 2024/03/06 17:46:47 UMIN ID1